James Huang - 19 Oct 2021 Form 4 Insider Report for WINDTREE THERAPEUTICS INC /DE/ (WINT)

Role
Director
Signature
/s/ John P. Hamill, as Attorney-in-Fact
Issuer symbol
WINT
Transactions as of
19 Oct 2021
Net transactions value
+$95,135
Form type
4
Filing time
19 Oct 2021, 16:56:06 UTC
Previous filing
03 Sep 2021
Next filing
26 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WINT Common Stock Purchase $95,135 +50,000 +21% $1.90 291,281 19 Oct 2021 Direct F1
holding WINT Common Stock 2,336,853 19 Oct 2021 Via Panacea Venture Healthcare Fund I L.P. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in multiple trades at prices ranging from $1.84 to $1.93. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 The Reporting Person is a Director of Panacea Venture Healthcare Fund GP I L.P. The Reporting Person disclaims beneficial ownership of the shares held by Panacea Venture Healthcare Fund I L.P., except to the extent of his pecuniary interest therein.